Medivir AB (publ) (STO: MVIR)
Sweden
· Delayed Price · Currency is SEK 2.820
-0.070 (-2.42%)
At close: Jan 29, 2025
Medivir AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 6.93 | 7.63 | 4.41 | 25.54 | 13.95 | 8.72 | Upgrade
|
| Other Revenue | 0.1 | - | - | 6.86 | 6.48 | - | Upgrade
|
| Revenue | 7.03 | 7.63 | 4.41 | 32.39 | 20.43 | 8.72 | Upgrade
|
| Revenue Growth (YoY) | 27.69% | 73.16% | -86.39% | 58.56% | 134.18% | -63.44% | Upgrade
|
| Cost of Revenue | 97.07 | 68.87 | 69.08 | 73.28 | 52.93 | 91.06 | Upgrade
|
| Gross Profit | -90.03 | -61.23 | -64.67 | -40.88 | -32.5 | -82.34 | Upgrade
|
| Selling, General & Admin | 28.27 | 27.37 | 20.74 | 21.42 | 24.93 | 35.03 | Upgrade
|
| Other Operating Expenses | 0.81 | 1.41 | 0.63 | -0.49 | -1.05 | 4.14 | Upgrade
|
| Operating Expenses | 31.72 | 31.52 | 23.94 | 23.52 | 28.31 | 46.26 | Upgrade
|
| Operating Income | -121.75 | -92.75 | -88.61 | -64.4 | -60.81 | -128.59 | Upgrade
|
| Interest Expense | -0.91 | -0.91 | -1.42 | -0.95 | -0.55 | -1.32 | Upgrade
|
| Interest & Investment Income | 5.21 | 3.01 | 0.01 | - | 0.07 | 1.36 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.34 | 1.34 | 1.22 | 1.6 | 1.29 | 4.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.8 | 0 | - | 0 | 16.03 | 1.14 | Upgrade
|
| EBT Excluding Unusual Items | -116.92 | -89.32 | -88.8 | -63.75 | -43.98 | -123.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.49 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.04 | 0.68 | 1.36 | - | Upgrade
|
| Pretax Income | -116.92 | -89.32 | -88.77 | -62.58 | -42.62 | -123.33 | Upgrade
|
| Income Tax Expense | - | - | - | 0.55 | - | 0.11 | Upgrade
|
| Earnings From Continuing Operations | -116.92 | -89.32 | -88.77 | -63.13 | -42.62 | -123.44 | Upgrade
|
| Net Income | -116.92 | -89.32 | -88.77 | -63.13 | -42.62 | -123.44 | Upgrade
|
| Net Income to Common | -116.92 | -89.32 | -88.77 | -63.13 | -42.62 | -123.44 | Upgrade
|
| Shares Outstanding (Basic) | 104 | 60 | 56 | 53 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 104 | 60 | 56 | 53 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | 84.59% | 8.44% | 5.53% | 117.45% | - | 1.38% | Upgrade
|
| EPS (Basic) | -1.13 | -1.48 | -1.59 | -1.20 | -1.75 | -5.08 | Upgrade
|
| EPS (Diluted) | -1.13 | -1.48 | -1.59 | -1.20 | -1.75 | -5.08 | Upgrade
|
| Free Cash Flow | -99.07 | -59.67 | -102.2 | -48.73 | -60.74 | -149.69 | Upgrade
|
| Free Cash Flow Per Share | -0.96 | -0.99 | -1.83 | -0.92 | -2.50 | -6.16 | Upgrade
|
| Gross Margin | - | - | - | -126.21% | -159.09% | - | Upgrade
|
| Operating Margin | -1731.17% | -1215.16% | -2010.16% | -198.80% | -297.65% | -1474.03% | Upgrade
|
| Profit Margin | -1662.48% | -1170.21% | -2013.73% | -194.87% | -208.61% | -1414.95% | Upgrade
|
| Free Cash Flow Margin | -1408.57% | -781.67% | -2318.56% | -150.44% | -297.29% | -1715.85% | Upgrade
|
| EBITDA | -121.72 | -92.62 | -88.4 | -64.08 | -59.2 | -124.96 | Upgrade
|
| EBITDA Margin | - | - | - | -197.81% | -289.77% | - | Upgrade
|
| D&A For EBITDA | 0.04 | 0.14 | 0.2 | 0.32 | 1.61 | 3.64 | Upgrade
|
| EBIT | -121.75 | -92.75 | -88.61 | -64.4 | -60.81 | -128.59 | Upgrade
|
| EBIT Margin | - | - | - | -198.80% | -297.65% | - | Upgrade
|
| Revenue as Reported | 7.8 | 9 | 6.23 | 35.74 | 41.26 | 11.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.